featured
ASCO 2017: Dr. David Henry on Preventing Febrile Neutropenia
Interview by
Interview with
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
- Abbasi S, Nazha B, Moussaly E, et al. Febrile neutropenia in the nationwide inpatient sample: In-hospital outcomes and impact of cormobidities in 2007-2012. Paper presented at: American Society of Clinical Oncology Annual Meeting; June 2-6, 2017; Chicago, IL. Abstract e18103.
- Patel K, Diergaarde B, Brufsky A, et al. Incidence of febrile neutropenia with use of docetaxel plus cyclophosphamide (TC) for breast cancer. Paper presented at: American Society of Clinical Oncology Annual Meeting; June 2-6, 2017; Chicago, IL. Abstract e12073.
- McBride A, Abraham I, MacDonald K, et al. Cost savings of conversion from filgrastim or pegfilgrastim to biosimilar filgrastim-sndz for chemotherapy-induced (febrile) neutropenia (CIN/FN) prophylaxis and expanded access to biosimilar GCSF on a budget neutral basis. Paper presented at: American Society of Clinical Oncology Annual Meeting; June 2-6, 2017; Chicago, IL. Abstract e18334.